Baxter International, Inc. acquired a Seprafilm Adhesion Barrier that greatly lowers the frequency, severity, and length of adhesions after abdominal and pelvic surgery from Sanofi to reduce the severity of adhesions in various pelvic and abdominal procedures and to guarantee a smooth transition by collaborating with consumers and distributors.
Baxter International, Inc. announced to acquisition of PerClot Polysaccharide Hemostatic System from CryoLife, Inc. to provide patients with the best possible treatment by addressing a variety of intraoperative bleeding and assisting surgeons in using the appropriate products for the hemorrhage.
Author Credits: Smruti Ranjan, Rajrani Baghel
Report ID: 4535
Published Date: Oct 20, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing number of surgical procedures and the growing technological advancements are the major factors driving the growth of the market.
The market size of the adhesion barrier is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.
The major players in the market are Becton Dickinson and Company, Baxter International, Inc., Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., Mast Biosurgery, Inc., Innocoll Holdings PLC, Atrium Medical Corporation.
The film/mesh segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.